BMI1 and Parkinson disease: It has been reported that miR-320a inhibits cell proliferation, migration, and invasion by targeting the BMI-1 gene in nasopharyngeal carcinoma [40], and may be implicated in the α-synuclein aggravation in Parkinson's disease [41].